BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36632253)

  • 1. Myeloproliferative Neoplasm and Myelodysplastic Syndrome-Associated Renal Disease: A Histopathological Report of Two Cases.
    Popov H; Koleva T; Stoyanov GS; Ghenev P
    Cureus; 2022 Dec; 14(12):e32388. PubMed ID: 36632253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms.
    Büttner-Herold M; Sticht C; Wiech T; Porubsky S
    Histopathology; 2021 Apr; 78(5):738-748. PubMed ID: 33078472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myeloproliferative neoplasms related glomerulopathy].
    Paule R; Ponsoye M; Gueutin V; Deray G; Izzedine H
    Rev Med Interne; 2013 Jun; 34(6):369-72. PubMed ID: 23357690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis.
    Wan Z; Han B
    Front Oncol; 2020; 10():579221. PubMed ID: 33117717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.
    Person F; Meyer SC; Hopfer H; Menter T
    Virchows Arch; 2021 Nov; 479(5):1013-1020. PubMed ID: 34164707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics.
    Tefferi A; Skoda R; Vardiman JW
    Nat Rev Clin Oncol; 2009 Nov; 6(11):627-37. PubMed ID: 19806146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia.
    Jekarl DW; Han SB; Kim M; Lim J; Oh EJ; Kim Y; Kim HJ; Min WS; Han K
    Korean J Hematol; 2010 Mar; 45(1):46-50. PubMed ID: 21120162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of HMGA2 in the proliferation and expansion of a hematopoietic cell in myeloproliferative neoplasms.
    Ikeda K; Ogawa K; Takeishi Y
    Fukushima J Med Sci; 2012; 58(2):91-100. PubMed ID: 23237864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia.
    Agarwal MB; Malhotra H; Chakrabarti P; Varma N; Mathews V; Bhattacharyya J; Seth T; Gayathri K; Menon H; Subramanian PG; Sharma A; Bhattacharyya M; Mehta J; Vaid AK; Shah S; Aggarwal S; Gogoi PK; Nair R; Agarwal U; Varma S; Prasad SV; Manipadam MT
    Indian J Med Paediatr Oncol; 2015; 36(1):3-16. PubMed ID: 25810569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloproliferative neoplasms cause glomerulopathy.
    Said SM; Leung N; Sethi S; Cornell LD; Fidler ME; Grande JP; Herrmann S; Tefferi A; D'Agati VD; Nasr SH
    Kidney Int; 2011 Oct; 80(7):753-9. PubMed ID: 21654720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Ringing in a new future.
    Nathan DI; Feld J; El Jamal SM; Mascarenhas J; Tremblay D
    Leuk Res; 2022 Apr; 115():106820. PubMed ID: 35279478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Detection of CALR-Mutated Cells in Myeloproliferative Neoplasm-Related Glomerulopathy With Interstitial Extramedullary Hematopoiesis: A Case Report.
    Maruyama K; Nakagawa N; Suzuki A; Kabara M; Matsuki M; Shindo M; Iwasaki S; Ogawa Y; Hasebe N
    Am J Kidney Dis; 2019 Dec; 74(6):844-848. PubMed ID: 31377025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
    Björkholm M; Derolf AR; Hultcrantz M; Kristinsson SY; Ekstrand C; Goldin LR; Andreasson B; Birgegård G; Linder O; Malm C; Markevärn B; Nilsson L; Samuelsson J; Granath F; Landgren O
    J Clin Oncol; 2011 Jun; 29(17):2410-5. PubMed ID: 21537037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM).
    Thepot S; Itzykson R; Seegers V; Raffoux E; Quesnel B; Chait Y; Sorin L; Dreyfus F; Cluzeau T; Delaunay J; Sanhes L; Eclache V; Dartigeas C; Turlure P; Harel S; Salanoubat C; Kiladjian JJ; Fenaux P; Adès L;
    Blood; 2010 Nov; 116(19):3735-42. PubMed ID: 20664061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic/myeloproliferative neoplasms.
    Hyjek E; Vardiman JW
    Semin Diagn Pathol; 2011 Nov; 28(4):283-97. PubMed ID: 22195406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN.
    Mestrum SGC; de Wit NCJ; Drent RJM; Hopman AHN; Ramaekers FCS; Leers MPG
    Cytometry B Clin Cytom; 2021 May; 100(3):322-330. PubMed ID: 32857909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes.
    Sochacki AL; Fischer MA; Savona MR
    Onco Targets Ther; 2016; 9():2273-86. PubMed ID: 27143923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current Understanding of Myeloproliferative Neoplasm-Related Gene Mutations and Cytokine -Review].
    He ZP; Wu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):589-594. PubMed ID: 29665937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent bilateral adrenal infarction with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U): a case report.
    Hoshino Y; Manaka K; Sato J; Asatsuma Y; Horikoshi H; Takeuchi M; Ito N; Fujita M; Yasunaga M; Matsuda K; Honda A; Maki H; Masamoto Y; Kurokawa M; Nangaku M; Makita N
    BMC Endocr Disord; 2023 Jun; 23(1):128. PubMed ID: 37277771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.